- Home
- CCB vs OCS Comparison
CCB vs OCS Comparison
Compare CCB & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCB
- OCS
- Stock Information
- Founded
- CCB 1997
- OCS 2003
- Country
- CCB United States
- OCS Switzerland
- Employees
- CCB N/A
- OCS N/A
- Industry
- CCB Major Banks
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- CCB Finance
- OCS Health Care
- Exchange
- CCB Nasdaq
- OCS Nasdaq
- Market Cap
- CCB 1.3B
- OCS 1.0B
- IPO Year
- CCB 2018
- OCS N/A
- Fundamental
- Price
- CCB $102.62
- OCS $19.00
- Analyst Decision
- CCB Strong Buy
- OCS Strong Buy
- Analyst Count
- CCB 3
- OCS 3
- Target Price
- CCB $103.33
- OCS $35.33
- AVG Volume (30 Days)
- CCB 136.9K
- OCS 26.7K
- Earning Date
- CCB 07-28-2025
- OCS 08-26-2025
- Dividend Yield
- CCB N/A
- OCS N/A
- EPS Growth
- CCB 17.53
- OCS N/A
- EPS
- CCB 3.36
- OCS N/A
- Revenue
- CCB $322,160,000.00
- OCS $847,333.00
- Revenue This Year
- CCB $109.11
- OCS $18.70
- Revenue Next Year
- CCB $36.30
- OCS $1,059.78
- P/E Ratio
- CCB $30.53
- OCS N/A
- Revenue Growth
- CCB 25.44
- OCS N/A
- 52 Week Low
- CCB $43.43
- OCS $10.79
- 52 Week High
- CCB $106.38
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- CCB 69.56
- OCS 46.89
- Support Level
- CCB $95.68
- OCS $18.87
- Resistance Level
- CCB $94.09
- OCS $19.75
- Average True Range (ATR)
- CCB 3.63
- OCS 0.43
- MACD
- CCB 1.52
- OCS -0.11
- Stochastic Oscillator
- CCB 85.39
- OCS 32.43
About CCB Coastal Financial Corporation
Coastal Financial Corp is a financial service provider. The company provides banking products and services to consumers and small to medium-sized businesses. Its business is conducted through three reportable segments: The community bank, CCBX, and treasury & administration. The primary focus of the community bank is on providing a wide range of banking products and services to consumers and small to medium-sized businesses in the broader Puget Sound region in the state of Washington and through the Internet and mobile banking applications.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.